- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant human alpha-glucosidase conjugated with multiple
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant human alpha-glucosidase conjugated with multiple copies of synthetic bismannose-6-phosphate-tetra-mannose glycan
| EU orphan designation number: | EU/3/14/1251
|
| Active ingredient: | Recombinant human alpha-glucosidase conjugated with multiple copies of synthetic bismannose-6-phosphate-tetra-mannose glycan |
| Indication: | Treatment of glycogen storage disease type II (Pompe's disease) |
| Sponsor: | Genzyme Europe B.V.
Gooimeer 10, NL-1411 DD Naarden, Nederland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 28/03/2014 | Orphan designation | EMA/OD/148/13 | (2014)2109 of 26/03/2014 |
CONTACT
EU links
Directorate General Health & Consumers